Related Experiment Videos
Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections
Insights
Children with sickle cell disease face high risks of pneumococcal infections. Early antibiotics, prophylaxis, and vaccination can effectively reduce pneumococcal disease incidence.
Area of Science:
- Pediatric Hematology
- Infectious Diseases
- Immunology
Background:
- Sickle cell disease (SCD) significantly increases young children's risk of severe pneumococcal sepsis and meningitis.
- Impaired splenic function, complement abnormalities, and insufficient pneumococcal antibodies contribute to infection susceptibility in SCD.
- Pneumococcal infections are a leading cause of morbidity and mortality in pediatric SCD patients.
Purpose of the Study:
- To outline a comprehensive strategy for preventing pneumococcal disease in children with sickle cell disease.
- To discuss the role of early intervention and prophylaxis in managing infection risk.
- To highlight other common and severe infections in pediatric SCD.
Main Methods:
- Review of existing literature and clinical guidelines for infection prevention in SCD.
- Emphasis on a multi-faceted approach including prompt antibiotic treatment, prophylactic antibiotics, and vaccination.
- Discussion of epidemiological data on specific pathogens like Salmonella, Haemophilus, and Mycoplasma.
Main Results:
- A combined strategy of early antibiotic therapy for febrile episodes, antimicrobial prophylaxis, and pneumococcal vaccination shows promise in reducing infection rates.
- Specific guidelines for infection prevention are proposed.
- Increased frequency and severity of other infections, including Salmonella, Haemophilus, and Mycoplasma, are noted in SCD patients.
Conclusions:
- A proactive, multi-pronged approach is crucial for preventing severe pneumococcal infections in children with sickle cell disease.
- Vaccination and prophylactic measures are key components of managing infection risk.
- Comprehensive care must also address other prevalent infections in this vulnerable population.
Abstract:
Pneumococcal sepsis and/or meningitis are major causes of morbidity and mortality in young children with sickle cell disease. Abnormal complement activity, poor splenic function and a lack of type-specific pneumococcal antibody are responsible for the severity and frequency of these infections. A program consisting of early institution of antibiotic therapy for febrile episodes, antimicrobial prophylaxis, and administration of pneumococcal vaccine may be effective in reducing the incidence of pneumococcal disease. Specific guidelines for infection prevention are presented. Other infections that are more frequent or more severe in children with sickle cell disease (e.g., Salmonella, Haemophilus and mycoplasma infections) are also discussed.